Abstract Policy

Abstract Submission deadline: Monday, Dec. 17, 2018

The Binaytara Foundation is awarding five $500.00 travel grants to first authors with the highest scoring abstracts. Those who receive one of the travel grants will also receive free registration to SCHD19. The next five abstracts with high scores will also be granted a registration waiver. All of those who submit an abstract are entered for a chance to win one of the travel grants. Grant winners will be notified after acceptance emails are sent.

We will accept abstracts in the following categories. Please select a category that fits the submission best, and indicate the category in your submission email:

– Database Analysis to Examine Cancer Health Disparities
– Outcome Analysis
– Quality Improvement and Oncology Pharmacy Projects
– Patient Navigation
– Program Development
– Applications of Technology in Addressing Issues in Cancer Health Disparity
– Cost of Care
– Access to Care and/or Cancer Prevention and Screening
– Survivorship
 General guidelines
  • Abstracts submitted should not have been previously published or presented at another meeting.
  • Abstracts must be written in the format provided.
  • Abstracts should be no more than 300 words (excluding abstract title, authors, and affiliations).
  • Abstracts should be written in English.
  • For both primary and co-authors, credentials along with their full first and last names and email addresses must be included. If co-authors are from different institutions, the secondary institution(s) and the institution investigators are associated with must be listed using a superscript.

For example:  Investigator Names:  Jane doe, MD 1, Jay Jones, MD, PHD2, Danny day, MD3

Institutions: 1) Hills Valley Cancer Institute, 2) River Town Cancer Care Center, 3) Cancer Doctors University

Submit Abstracts by emailing: [email protected]

Authors will be notified of acceptance or rejection via email.